Loading...
Docoh

Harvard Bioscience (HBIO)

Harvard Bioscience is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its customers range from renowned academic institutions and government laboratories, to the world's leading pharmaceutical, biotechnology and contract research organizations. With operations in North America, Europe, and China, the company sells through a combination of direct and distribution channels to customers around the world.

Company profile

Ticker
HBIO
Exchange
CEO
James W. Green
Employees
Incorporated
Location
Fiscal year end
SEC CIK
Subsidiaries
AHN Acquisition GmbH • Asys Hitech GmbH • Biochrom Limited • Biochrom US, Inc. • Biodrop Ltd. • Cartesian Technologies, Inc. • CMA Microdialysis Ab • Coulbourn Instruments, LLC • Data Sciences International, Inc. • Data Sciences (UK) Mn, Ltd. ...
IRS number
43306140

HBIO stock data

Analyst ratings and price targets

Last 3 months

Calendar

4 Aug 22
27 Sep 22
31 Dec 22
Quarter (USD) Jun 22 Mar 22 Dec 21 Sep 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 4.26M 4.26M 4.26M 4.26M 4.26M 4.26M
Cash burn (monthly) 391.33K 164.83K (no burn) 64.42K 63.33K 226.58K
Cash used (since last report) 1.15M 483.76K n/a 189.05K 185.87K 664.99K
Cash remaining 3.11M 3.78M n/a 4.07M 4.07M 3.59M
Runway (months of cash) 7.9 22.9 n/a 63.2 64.3 15.9

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
6 Sep 22 Bertrand Loy Common Stock Other Dispose J Yes No 0 108,715 0 0
26 Aug 22 Bertrand Loy Common Stock Buy Acquire P No No 3.41 9,291 31.68K 399,651
25 Aug 22 Bertrand Loy Common Stock Buy Acquire P No No 3.34 8,244 27.53K 390,360
24 Aug 22 Bertrand Loy Common Stock Buy Acquire P No No 3.23 17,291 55.85K 382,116
23 Aug 22 Bertrand Loy Common Stock Buy Acquire P No No 3.23 8,939 28.87K 364,825
22 Aug 22 Bertrand Loy Common Stock Buy Acquire P No No 3.16 4,918 15.54K 355,886
19 Aug 22 Bertrand Loy Common Stock Buy Acquire P No No 3.28 9,608 31.51K 350,968
18 Aug 22 Bertrand Loy Common Stock Buy Acquire P No No 3.19 1,151 3.67K 341,360
71.2% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 89 96 -7.3%
Opened positions 21 7 +200.0%
Closed positions 28 13 +115.4%
Increased positions 29 27 +7.4%
Reduced positions 30 40 -25.0%
13F shares Current Prev Q Change
Total value 4.64B 187.25M +2376.9%
Total shares 29.65M 30.16M -1.7%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners Shares Value Change
Harvey Partners 2.87M $10.31M +28.7%
Punch & Associates Investment Management 2.65M $9.56M +7.7%
Portolan Capital Management 2.45M $8.83M -3.0%
Dimensional Fund Advisors 1.88M $6.76M -0.0%
Royce & Associates 1.62M $5.83M -3.9%
272 Capital 1.54M $5.56M +71.9%
Vanguard 1.54M $5.54M -20.1%
Granahan Investment Management 1.53M $5.52M +5.2%
AMH Equity 1.25M $4.5B +61.0%
BLK Blackrock 1.21M $4.35M -60.5%
Largest transactions Shares Bought/sold Change
BLK Blackrock 1.21M -1.85M -60.5%
272 Capital 1.54M +646.21K +71.9%
Harvey Partners 2.87M +639K +28.7%
STT State Street 127.55K -615.38K -82.8%
AMH Equity 1.25M +473.75K +61.0%
Essex Investment Management 0 -431.85K EXIT
Vanguard 1.54M -386.23K -20.1%
Kennedy Capital Management 331.91K +331.91K NEW
Millennium Management 390.97K +314.41K +410.7%
Geode Capital Management 335.69K -313.64K -48.3%

Financial report summary

?

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. junior Avg
New words: accrual, anticipate, benchmark, cellular, conflict, consecutive, dismissal, disruption, fluctuate, high, history, identical, iii, inflation, inflationary, mandatorily, Marketplace, military, molecular, Nasdaq, observable, offering, orderly, OTCQB, pari, passu, percentage, placement, private, qualified, qualifying, quoted, raw, Russia, thereon, Ukraine, uncertain, unchanged, unpaid, uplisting
Removed: declared, distancing, essential, force, implementing, indemnify, mix, organization, partially, planning, production, rapidly, RSU, significantly, social, world